From ASCVD Pooled Cohort Equations to PREVENT: Rethinking Cardiovascular Risk
From MDAware: Upgrading Clinical Judgment · 24:33
Show by MDCalc
In this episode of MDAware: Upgrading Clinical Judgment, Dr. Shazia Siddique talks with Dr. Sadiya Khan and Dr. Donald Lloyd-Jones about the PREVENT equations and why they're replacing the atherosclerotic cardiovascular disease (ASCVD) pooled cohort equations (PCEs) that have guided cardiovascular risk assessment for over a decade. A conversation about what changes when a risk tool expands beyond a single disease outcome, and why the same patient can get two different risk numbers depending on which calculator a clinician reaches for, and how this shapes the treatment conversation.Dr. Khan is a preventive cardiologist at Northwestern who led the development and validation of the PREVENT equations. Dr. Lloyd-Jones directs the Framingham Heart Study and was a lead voice on risk assessment going back to the original pooled cohort equations. Together they trace the full arc: from the 1998 Framingham risk equations, built almost entirely on a European ancestry population, to the 2013 pooled cohort equations, to PREVENT itself, which now accounts for coronary heart disease, stroke, and heart failure in a single model, drawing on data from more than six million individuals.Dr. Khan and Dr. Lloyd-Jones also walk through one of the more consequential decisions behind PREVENT: removing race as a variable in the equations, and why that decision didn't come at the cost of accuracy across different populations. From there, the conversation moves into how PREVENT is already being applied in the 2025 blood pressure guidelines, the CPR framework (calculate, personalize, reclassify) for translating a risk score into an actual treatment conversation, and what role tools like coronary artery calcium scoring play when the picture still isn't clear.What You'll LearnWhy coronary heart disease alone was an inadequate endpoint for risk prediction, and how leaving stroke and heart failure out of the equation left real risk on the table, particularly for women and Black AmericansWhy and how PREVENT drops race as a predictor in favor of directly measured risk factorsWhat CPR (calculate, personalize, reclassify) means in practiceHow the new 2025 blood pressure guidelines arrived at the PREVENT CVD 7.5% thresholdWhy a risk score can tell you where a patient stands today, but can't calculate the benefit of a hypothetical intervention, and why that distinction matters at the bedsideLinks & ResourcesMDCalc: mdcalc.comFollow MDCalc on LinkedIn: linkedin.com/company/mdcalcFollow MDCalc on X/Twitter: @MDCalc
More episodes of MDAware: Upgrading Clinical Judgment
More episodes
- The NEJM Challenge: Reassessing Race in Clinical Algorithms
- A Second Layer of Safety: MDCalc and AMBOSS partner on CrossCover and Clinical AI
- How to Drive Department Collaboration and Physician Adoption: Dr Howard Dinh’s Quest at Kaiser Permanente
- Grading the Calculators: Inside MDCalc's Quality Rating System
- Assessing Surgical Risk in Cirrhosis
- Who's Responsible When AI Gets It Wrong? | Dr. Sarah Gebauer on Healthcare AI Governance
- Guideline-Directed PE Care: The Diagnostic Tools You Need at the Bedside
- Guideline-Directed PE Care: The Management Tools You Need at the Bedside
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.